Tags

Type your tag names separated by a space and hit enter

Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Surv Ophthalmol. 2004 Sep-Oct; 49(5):537-40.SO

Abstract

Fluorine-18 fluordeoxyglucose positron emission tomography (FDG-PET) is an useful tool in diagnosing and monitoring of malignant cutaneous melanoma. However, the feasibility and usefulness of FDG-PET in uveal melanoma is not yet established. We present a patient with suspected advanced uveal melanoma who underwent combined FDG-PET/computed tomography (CT) for staging. FDG-PET/CT images demonstrated vital intraocular tumor. Anatomical assignment of the malignancy to the choroid was possible by means of the coregistered computed tomography. Furthermore, PET revealed an unknown otherwise undetected vital liver metastasis. We conclude that combined FDG-PET/CT has potential to further improve staging and therapy planning in patients with advanced uveal melanoma.

Authors+Show Affiliations

Department of Nuclear Medicine, University Hospital, Essen, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

15325198

Citation

Freudenberg, L S., et al. "Whole-body Fluorine-18 Fluordeoxyglucose Positron Emission Tomography/computed Tomography (FDG-PET/CT) in Staging of Advanced Uveal Melanoma." Survey of Ophthalmology, vol. 49, no. 5, 2004, pp. 537-40.
Freudenberg LS, Schueler AO, Beyer T, et al. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. Surv Ophthalmol. 2004;49(5):537-40.
Freudenberg, L. S., Schueler, A. O., Beyer, T., Antoch, G., Kühl, H., Bornfeld, N., Bockisch, A., & Egelhof, T. (2004). Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. Survey of Ophthalmology, 49(5), 537-40.
Freudenberg LS, et al. Whole-body Fluorine-18 Fluordeoxyglucose Positron Emission Tomography/computed Tomography (FDG-PET/CT) in Staging of Advanced Uveal Melanoma. Surv Ophthalmol. 2004 Sep-Oct;49(5):537-40. PubMed PMID: 15325198.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. AU - Freudenberg,L S, AU - Schueler,A O, AU - Beyer,T, AU - Antoch,G, AU - Kühl,H, AU - Bornfeld,N, AU - Bockisch,A, AU - Egelhof,T, PY - 2004/8/25/pubmed PY - 2004/11/13/medline PY - 2004/8/25/entrez SP - 537 EP - 40 JF - Survey of ophthalmology JO - Surv Ophthalmol VL - 49 IS - 5 N2 - Fluorine-18 fluordeoxyglucose positron emission tomography (FDG-PET) is an useful tool in diagnosing and monitoring of malignant cutaneous melanoma. However, the feasibility and usefulness of FDG-PET in uveal melanoma is not yet established. We present a patient with suspected advanced uveal melanoma who underwent combined FDG-PET/computed tomography (CT) for staging. FDG-PET/CT images demonstrated vital intraocular tumor. Anatomical assignment of the malignancy to the choroid was possible by means of the coregistered computed tomography. Furthermore, PET revealed an unknown otherwise undetected vital liver metastasis. We conclude that combined FDG-PET/CT has potential to further improve staging and therapy planning in patients with advanced uveal melanoma. SN - 0039-6257 UR - https://www.unboundmedicine.com/medline/citation/15325198/Whole_body_fluorine_18_fluordeoxyglucose_positron_emission_tomography/computed_tomography__FDG_PET/CT__in_staging_of_advanced_uveal_melanoma_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0039-6257(04)00115-8 DB - PRIME DP - Unbound Medicine ER -